These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12918680)

  • 21. HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behçet's disease.
    Aramaki K; Kikuchi H; Hirohata S
    Mod Rheumatol; 2007; 17(1):81-2. PubMed ID: 17278029
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
    Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
    Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary association of HLA-B51 with Behçet's disease in Ireland.
    Kilmartin DJ; Finch A; Acheson RW
    Br J Ophthalmol; 1997 Aug; 81(8):649-53. PubMed ID: 9349151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on HLA system of family members with Behçet's disease].
    Ohno S; Ichiishi A; Awata K; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1989 Feb; 93(2):215-7. PubMed ID: 2773703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-B51 negative monozygotic twins discordant for Behçet's disease.
    Gül A; Inanç M; Ocal L; Aral O; Carin M; Koniçe M
    Br J Rheumatol; 1997 Aug; 36(8):922-3. PubMed ID: 9291866
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.
    Atalay A; Yildiz-Demirtepe S; Tatlipinar S; Sanli-Erdoğan B; Cobankara V; Yildirim C; Bağci H; Atalay EO
    Mol Biol Rep; 2008 Sep; 35(3):345-9. PubMed ID: 17594535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice.
    Takeno M; Kariyone A; Yamashita N; Takiguchi M; Mizushima Y; Kaneoka H; Sakane T
    Arthritis Rheum; 1995 Mar; 38(3):426-33. PubMed ID: 7880197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Behçet's disease and association with HLA-B51 expression.
    Sakly K; Lahmar R; Nefzi F; Hammami S; Harzallah O; Sakly N; Sakly W; Hassine M; Mahjoub S; Ghedira I; Feki S
    Immunol Invest; 2014; 43(5):463-78. PubMed ID: 24661088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians.
    Baricordi OR; Sensi A; Pivetti-Pezzi P; Perrone S; Balboni A; Catarinelli G; Filippi F; Melchiorri L; Moncada A; Mattiuz PL
    Hum Immunol; 1986 Nov; 17(3):297-301. PubMed ID: 2432045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Close association of HLA-Bw51 with Behçet's disease.
    Ohno S; Ohguchi M; Hirose S; Matsuda H; Wakisaka A; Aizawa M
    Arch Ophthalmol; 1982 Sep; 100(9):1455-8. PubMed ID: 6956266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease.
    Kaya TI; Dur H; Tursen U; Gurler A
    Clin Exp Dermatol; 2002 Sep; 27(6):498-501. PubMed ID: 12372094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease.
    Krause L; Köhler AK; Altenburg A; Papoutsis N; Zouboulis CC; Pleyer U; Stroux A; Foerster MH
    Eye (Lond); 2009 May; 23(5):1182-6. PubMed ID: 18551141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of familial occurrence of Behçet's disease with and without ocular lesions.
    Nishiyama M; Nakae K; Umehara T
    Jpn J Ophthalmol; 2001; 45(3):313-6. PubMed ID: 11369384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histocompatibility antigens associated with Behçet's disease in northern Han Chinese.
    Mineshita S; Tian D; Wang LM; Jian XY; Li SY; Fang GZ; Bian TY; Liao HS; Tsuchida M; Tanaka H
    Intern Med; 1992 Sep; 31(9):1073-5. PubMed ID: 1421711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behçet's disease: the first Mongolian case in literature showing HLA B51, MICA gene type *5/*6.
    Chung YL; Bang DS; Lee ES; Lee SN; Mok JW; Park KS
    Yonsei Med J; 2003 Oct; 44(5):935-8. PubMed ID: 14584116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
    Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
    Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behçet's disease in patients of west African and Afro-Caribbean origin.
    Poon W; Verity DH; Larkin GL; Graham EM; Stanford MR
    Br J Ophthalmol; 2003 Jul; 87(7):876-8. PubMed ID: 12812890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A complete type patient with Behçet's disease associated with HLA-B*5102.
    Mizuki N; Inoko H; Ishihara M; Ando H; Nakamura S; Nishio M; Ohno S
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):757-8. PubMed ID: 7747590
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of an oligochip for genotyping human leukocyte antigen-B51 and its clinical application.
    Wang YS; Ma XL; Sun SH; Sun Y; Yu B
    Genet Test; 2005; 9(4):292-6. PubMed ID: 16379541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of articular manifestations in Behçet's disease: five-year report.
    Fatemi A; Shahram F; Akhlaghi M; Smiley A; Nadji A; Davatchi F
    Int J Rheum Dis; 2017 Jan; 20(1):97-102. PubMed ID: 26111117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.